PharmaEngine (ROCO:4162) Ending Cash Position : NT$3,011 Mil (As of Mar. 2025)

View and export this data going back to 2012. Start your Free Trial

What is PharmaEngine Ending Cash Position?

PharmaEngine's Ending Cash Position for the quarter that ended in Mar. 2025 was NT$3,011 Mil.

PharmaEngine's quarterly Ending Cash Position increased from Sep. 2024 (NT$710 Mil) to Dec. 2024 (NT$994 Mil) and increased from Dec. 2024 (NT$994 Mil) to Mar. 2025 (NT$3,011 Mil).

PharmaEngine's annual Ending Cash Position declined from Dec. 2022 (NT$1,769 Mil) to Dec. 2023 (NT$876 Mil) but then increased from Dec. 2023 (NT$876 Mil) to Dec. 2024 (NT$994 Mil).

PharmaEngine Ending Cash Position Historical Data

The historical data trend for PharmaEngine's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaEngine Ending Cash Position Chart

PharmaEngine Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

1,835.74

2,150.67

1,768.86

875.62

993.70

PharmaEngine Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Ending Cash Position	Get a 7-Day Free Trial															939.99	1,286.74	709.54	993.70	3,010.54

PharmaEngine Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

PharmaEngine's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	875.617	+	118.082
	=	994

PharmaEngine's Ending Cash Position for the quarter that ended in Mar. 2025 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	993.699	+	2016.844
	=	3,011

PharmaEngine Ending Cash Position Related Terms

Thank you for viewing the detailed overview of PharmaEngine's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaEngine Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaEngine Inc (ROCO:4162) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

10 Minsheng East Road, 11th Floor, Section 3, Taipei, TWN, 104

Website

https://www.pharmaengine.com

PharmaEngine Inc is a biopharmaceutical company engaged in the development of new drugs and therapeutic drugs for cancer. It is a specialty pharma company that adopts the no research, development-only model and the networked pharma model for new drug development. Its projects pipeline are: ONIVYDE was approved by the U.S. FDA, Taiwan FDA, and EMA for patients with gemcitabine-treated metastatic pancreatic cancer; and PEP07. It generates the revenue from Sales of goods.

PharmaEngine Headlines

No Headlines